BNT162b2 boosted neutralizing antibody titers after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination

被引：0
|
作者：
Hammerschmidt, S. I. [1 ]
Barros-Martins, J. [1 ]
Cossmann, A. [2 ]
Ramos, G. Morillas [2 ]
Stankow, M. V. [2 ]
Odak, I. [1 ]
Dopfer-Jablonka, A. [2 ,3 ]
Hetzel, L. [2 ]
Koehler, M. [1 ]
Patzer, G. [1 ]
Binz, C. [1 ]
Ritter, C. [1 ]
Friedrichsen, M. [1 ]
Schultze-Florey, C. [1 ,4 ]
Ravens, I. [1 ]
Willenzon, S. [1 ]
Bubke, A. [1 ]
Ristenpart, J. [1 ]
Janssen, A. [1 ]
Ssebyatika, G. [5 ]
Kraehling, V. [6 ,7 ]
Bernhardt, G. [1 ]
Hoffmann, M. [8 ,9 ]
Poehlmann, S. [8 ,9 ]
Krey, T. [5 ,10 ]
Bosnjak, B. [1 ]
Foester, R. [1 ,3 ,11 ]
Behrens, G. M. N. [2 ,3 ,12 ]
机构：
[1] Hannover Med Sch, Inst Immunol, Hannover, Germany
[2] Hannover Med Sch, Dept Rheumatol & Immunol, Hannover, Germany
[3] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany
[4] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany
[5] Univ Lubeck, Inst Biochem, Lubeck, Germany
[6] Philipps Univ Marburg, Inst Virol, Marburg, Germany
[7] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Marburg, Germany
[8] German Primate Ctr, Infect Biol Unit, Gottingen, Germany
[9] Georg August Univ Gottingen, Fac Biol & Psychol, Hannover, Germany
[10] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig & Partner Site, Hamburg, Germany
[11] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany
[12] Ctr Individualized Infect Med CiiM, Hannover, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 005
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [31] Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients
    Debie, Y.
    Van Audenaerde, J.
    Vandamme, T.
    Croes, L.
    Teuwen, L-A. M. N.
    Verbruggen, L.
    Vanhoutte, G.
    Marcq, E.
    Le Blon, D.
    Peeters, B.
    Goossens, M. E.
    Arien, K.
    Anguille, S.
    Smits, E.
    Vulsteke, C.
    Lion, E.
    Peeters, M.
    van Dam, P. A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1305 - S1305
  • [32] Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
    Witberg, Guy
    Magen, Ori
    Hoss, Sara
    Talmor-Barkan, Yeela
    Richter, Ilan
    Wiessman, Maya
    Aviv, Yaron
    Grinberg, Tzlil
    Shiyovich, Arthur
    Schamroth-Pravda, Nili
    Auster, Oren
    Dagan, Noa
    Birk, Einat
    Balicer, Ran
    Kornowski, Ran
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (19): : 1816 - 1817
  • [33] Acute interstitial nephritis after vaccination with BNT162b2
    Sonja Rieckmann
    Felix S. Seibert
    Maximilian Hogeweg
    Sebastian Bertram
    Adrian A. N. Doevelaar
    Kerstin Amann
    Nina Babel
    Timm H. Westhoff
    Journal of Nephrology, 2022, 35 : 779 - 782
  • [34] Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
    Mevorach, Dror
    Anis, Emilia
    Cedar, Noa
    Hasin, Tal
    Bromberg, Michal
    Goldberg, Lital
    Parnasa, Elchanan
    Dichtiar, Rita
    Hershkovitz, Yael
    Ash, Nachman
    Green, Manfred S.
    Keinan-Boker, Lital
    Alroy-Preis, Sharon
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10): : 998 - 999
  • [35] Profound decline of antibody titers 6 months after BNT162b2 vaccination in healthy volunteers
    Kozakai, Rikei
    Hoshi, Kuniko
    Izumi, Yoshihiko
    Takahashi, Shinichiro
    JOURNAL OF LABORATORY MEDICINE, 2022, 46 (02) : 147 - 149
  • [36] Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2
    Speer, Claudius
    Benning, Louise
    Toellner, Maximilian
    Nusshag, Christian
    Kalble, Florian
    Reichel, Paula
    Schaier, Matthias
    Bartenschlager, Marie
    Schnitzler, Paul
    Zeier, Martin
    Susal, Caner
    Morath, Christian
    Bartenschlager, Ralf
    KIDNEY INTERNATIONAL, 2021, 100 (03) : 700 - 702
  • [37] The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population
    Damour, Alexia
    Faure, Muriel
    Landrein, Nicolas
    Ragues, Jessica
    Ardah, Narda
    Dhaidel, Haneen
    Lafon, Marie-Edith
    Wodrich, Harald
    Basha, Walid
    VACCINES, 2024, 12 (05)
  • [38] Beyond neutralization for BNT162b2 mRNA vaccination
    Damani-Yokota, Payal
    Yeung, Stephen T.
    Khanna, Kamal M.
    CELL HOST & MICROBE, 2021, 29 (07) : 1033 - 1035
  • [39] Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
    Eduardo Hermosilla
    Ermengol Coma
    Junqing Xie
    Shuo Feng
    Carmen Cabezas
    Leonardo Méndez-Boo
    Francesc Fina
    Elisabet Ballo
    Montserrat Martínez
    Manuel Medina-Peralta
    Josep Maria Argimon
    Daniel Prieto-Alhambra
    Nature Communications, 13
  • [40] Age and smoking predict antibody titers after the BNT162b2 COVID-19 vaccine
    O'Rourke, Kate
    CANCER, 2022, 128 (03) : 431 - 431
12345